Plaque erosion risk and JAK2 V617F variant

被引:0
|
作者
Wang, Shengfang [1 ,2 ,3 ]
Luo, Xing [1 ,3 ]
Hu, Sining [1 ,3 ]
Zhao, Chen [1 ,3 ]
Sun, Qianhui [1 ,3 ]
Zeng, Ming [1 ,3 ]
Bao, Xiaoyi [1 ,3 ]
Wang, Yini [1 ,3 ]
Wu, Fangfang [4 ]
Yang, Yeqiu [1 ,3 ]
Lv, Ying [1 ,3 ]
Bai, Xiaoxuan [1 ,3 ]
Hao, Wei [1 ,3 ]
Liu, Minghao [1 ,3 ]
Yi, Boling [1 ,3 ]
Chen, Yuwu [1 ,3 ]
Meng, Wei [1 ,3 ]
Li, Ji [1 ,3 ]
Li, Man [1 ,3 ]
Huang, Jianxin [1 ,3 ]
Wu, Tianyu [1 ,3 ]
Zhao, Yipin [2 ]
Zhang, Zhulin [5 ]
An, Jian [6 ]
Libby, Peter [7 ]
Jia, Haibo [1 ,3 ]
Yu, Bo [1 ,3 ]
机构
[1] Harbin Med Univ, Coll Pharm,Affiliated Hosp 2, Dept Pharmacol, State Key Lab Frigid Zone Cardiovasc Dis SKLFZCD, 246 Xuefu Rd, Harbin 150000, Peoples R China
[2] Zhengzhou Univ, Cent China Fuwai Hosp, Henan Prov Peoples Hosp Heart Ctr, Dept Cardiol, 1 Fuwai Ave, Zhengzhou 451464, Henan, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150086, Peoples R China
[4] Northeast Agr Univ, Coll Arts & Sci, 600 Changjiang Rd, Harbin 150030, Peoples R China
[5] Shanxi Cardiovasc Hosp, Dept Cardiol, 18 Yifen St, Taiyuan, Peoples R China
[6] Northeast Agr Univ, Coll Engn, 101 Xuefu St, Harbin 150030, Peoples R China
[7] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Div Cardiovasc Med, Boston, MA USA
基金
中国国家自然科学基金;
关键词
Clonal haematopoiesis; Myocardial infarction; JAK2; V617F; Plaque erosion; Neutrophil; VIMENTIN INTERMEDIATE-FILAMENTS; ACUTE CORONARY SYNDROMES; CLONAL HEMATOPOIESIS; NEUTROPHIL RECRUITMENT; EXTRACELLULAR-MATRIX; HEART-FAILURE; HYALURONAN; ATHEROSCLEROSIS; INFLAMMATION; MECHANISMS;
D O I
10.1093/eurheartj/ehaf114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Aims Clonal haematopoiesis of indeterminate potential (CHIP) can increase the risk of myocardial infarction (MI). Among various CHIP mutations, JAK2 V617F substantially elevated this risk. However, the specific associations between JAK2 V617F and two mechanisms of MI, plaque erosion and plaque rupture, remain unclear. Methods Case-control studies investigated these associations. A total of 728 erosion cases, 919 rupture cases, and 804 controls were included from our centre. Digital-drop polymerase chain reaction was performed on these individuals to identify the presence of JAK2 V617F. Previous experimental work has implicated neutrophils in the pathogenesis of erosion in the presence of this mutation. Thus, single-cell RNA sequencing of neutrophils from both JAK2 V617F carriers and healthy donors was performed to seek the potential mechanisms responsible for erosion associated with JAK2 V617F. Results Among the participants, 26 (3.57%) erosion patients, 7 (.76%) rupture patients, and 3 (.37%) controls were identified as JAK2 V617F carriers with a variant allele frequency (VAF) >= 1%. The carriers among the erosion patients exhibited higher platelet counts and lower glycated haemoglobin and blood lipid levels. Logistic regression analysis, considering erosion or rupture as separate cases, revealed that JAK2 V617F carriers with a VAF >= 1% showed a significant association with erosion [odds ratio (OR) 16.246, 95% confidence interval (CI) 4.624-57.080, P < .0001], but not with rupture (OR 1.677, 95% CI .379-7.415, P = .495). Single-cell RNA-sequencing data indicated that neutrophils from JAK2 V617F carriers displayed augmented expression levels of genes and gene sets associated with activation, adhesion, migration, and granule secretion. Conclusions JAK2 V617F linked to a high risk of erosion, an association to which enhanced neutrophil activation may contribute.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] JAK2V617F and ischemic stroke: CHIP or CMD-NBV?
    Barosi, Giovanni
    Rosti, Vittorio
    Gale, Robert Peter
    BLOOD ADVANCES, 2023, 7 (23) : 7329 - 7330
  • [32] No Differences in Outcomes Between JAK2 V617F-Positive Patients with Variant Allele Fraction &lt; 2% Versus 2-10%: A 6-Year Province-wide Retrospective Analysis
    Limvorapitak, Wasithep
    Parker, Jeremy
    Hughesman, Curtis
    McNeil, Kelly
    Foltz, Lynda
    Karsan, Aly
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (09) : E569 - E578
  • [33] Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis
    Liu, Wenli
    Ostberg, Nataliya
    Yalcinkaya, Mustafa
    Dou, Huijuan
    Endo-Umeda, Kaori
    Tang, Yang
    Hou, Xintong
    Xiao, Tong
    Fidler, Trevor P.
    Abramowicz, Sandra
    Yang, Yong-Guang
    Soehnlein, Oliver
    Tall, Alan R.
    Wang, Nan
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (13)
  • [34] High JAK2V617F variant allele frequency is associated with coronary artery but not aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms
    Solli, Camilla Nordheim
    Chamat-Hedemand, Sandra
    Elming, Hanne
    Ngo, Anh
    Kjaer, Lasse
    Skov, Vibe
    Sorensen, Anders Lindholm
    Ellervik, Christina
    Hasselbalch, Hans
    Bruun, Niels Eske
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (03) : 400 - 406
  • [35] Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
    Lima, Keli
    Elias Godoy Carlos, Jorge Antonio
    Alves-Paiva, Raquel de Melo
    Vicari, Hugo Passos
    de Souza Santos, Fabio Pires
    Hamerschlak, Nelson
    Costa-Lotufo, Leticia Veras
    Traina, Fabiola
    Machado-Neto, Joao Agostinho
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [36] Jak2V617F clonal hematopoiesis promotes arterial thrombosis via platelet activation and cross talk
    Liu, Wenli
    Pircher, Joachim
    Schuermans, Art
    Ul Ain, Qurrat
    Zhang, Zhe
    Honigberg, Michael C.
    Yalcinkaya, Mustafa
    Nakao, Tetsushi
    Pournamadri, Ashley
    Xiao, Tong
    Hajebrahimi, Mohammad Ali
    Wasner, Lisa
    Stegner, David
    Petzold, Tobias
    Natarajan, Pradeep
    Massberg, Steffen
    Tall, Alan R.
    Schulz, Christian
    Wang, Nan
    BLOOD, 2024, 143 (15) : 1539 - 1550
  • [37] Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice
    Shi, Kaiyao
    Zhao, Wanke
    Chen, Yun
    Ho, Wanting Tina
    Yang, Ping
    Zhao, Zhizhuang Joe
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
  • [38] JAK2 Variant Signaling: Genetic, Hematologic and Immune Implication in Chronic Myeloproliferative Neoplasms
    Torres, Dania G.
    Paes, Jhemerson
    da Costa, Allyson G.
    Malheiro, Adriana
    Silva, George V.
    Mourao, Lucivana P. de Souza
    Tarrago, Andrea M.
    BIOMOLECULES, 2022, 12 (02)
  • [39] Vitamin D Deficiency and Janus kinase 2 V617F Mutation Status in Essential Thrombocythemia and Polycythemia Vera
    Yikilmaz, Aysun Senturk
    Akinci, Sema
    Bakanay, Sule Mine
    Dilek, Imdat
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2020, 27 (01): : 70 - 77
  • [40] JAK2V617F Mutation in Chronic Myeloid Leukemia Predicts Early Disease Progression
    Pahore, Zaen-Al-Abideen
    Shamsi, Tahir S.
    Taj, Mehwesh
    Farzana, Tasneem
    Ansari, Saqib H.
    Nadeem, Muhammad
    Ahmad, Masood
    Naz, Arshi
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2011, 21 (08): : 472 - 475